Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abinash Mallick

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Computational and Structural Biotechnology Journal|December 26, 2025
Decoding the cross-immune pressure: Dengue's role in SARS-CoV-2 evolutionAbinash Mallick, Rudra Chhajer, Subhajit Biswas
Journal of Medical Virology|June 27, 2024
Evidences support that dengue virus can impart broad-spectrum immunity against betacoronaviruses in dengue endemic regionsAbinash Mallick, Soumi Sukla, Abhishek De, et al.
Computational and Structural Biotechnology Journal|January 4, 2021
Computational modelling supports that dengue virus envelope antibodies can bind to SARS-CoV-2 receptor binding sites: Is pre-exposure to dengue virus protective against COVID-19 severity?Himadri Nath, Abinash Mallick, Subrata Roy, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 8, 2021
Regarding: Masyeni S, Santoso MS, Widyaningsih PD, Wedha Asmara DG, Nainu F, Harapan H, et al. Serological cross-reaction and co-infection of dengue and COVID-19 in Asia: Experience from Indonesia. Int J Infect Dis 2020;102:152-4. https://doi.org/10.1016/j.ijid.2020.10.043Subhajit Biswas, Soumi Sukla, Subrata Roy, et al.
Journal of Medical Microbiology|June 10, 2021
Archived dengue serum samples produced false-positive results in SARS-CoV-2 lateral flow-based rapid antibody testsHimadri Nath, Abinash Mallick, Subrata Roy, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 10, 2022
COVID-19 serum can be cross-reactive and neutralizing against the dengue virus, as observed by the dengue virus neutralization testHimadri Nath, Abinash Mallick, Subrata Roy, et al.
Journal of Medical Microbiology|July 4, 2024
Dengue virus (DV) non-cross-reactive Omicron wave COVID-19 serums enhanced DV3 infectivity <i>in vitro</i>Supratim Sarker, Chiroshri Dutta, Abinash Mallick, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Computational and Structural Biotechnology Journal|December 26, 2025
Decoding the cross-immune pressure: Dengue's role in SARS-CoV-2 evolutionAbinash Mallick, Rudra Chhajer, Subhajit Biswas
Journal of Medical Virology|June 27, 2024
Evidences support that dengue virus can impart broad-spectrum immunity against betacoronaviruses in dengue endemic regionsAbinash Mallick, Soumi Sukla, Abhishek De, et al.
Computational and Structural Biotechnology Journal|January 4, 2021
Computational modelling supports that dengue virus envelope antibodies can bind to SARS-CoV-2 receptor binding sites: Is pre-exposure to dengue virus protective against COVID-19 severity?Himadri Nath, Abinash Mallick, Subrata Roy, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 8, 2021
Regarding: Masyeni S, Santoso MS, Widyaningsih PD, Wedha Asmara DG, Nainu F, Harapan H, et al. Serological cross-reaction and co-infection of dengue and COVID-19 in Asia: Experience from Indonesia. Int J Infect Dis 2020;102:152-4. https://doi.org/10.1016/j.ijid.2020.10.043Subhajit Biswas, Soumi Sukla, Subrata Roy, et al.
Journal of Medical Microbiology|June 10, 2021
Archived dengue serum samples produced false-positive results in SARS-CoV-2 lateral flow-based rapid antibody testsHimadri Nath, Abinash Mallick, Subrata Roy, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 10, 2022
COVID-19 serum can be cross-reactive and neutralizing against the dengue virus, as observed by the dengue virus neutralization testHimadri Nath, Abinash Mallick, Subrata Roy, et al.
Journal of Medical Microbiology|July 4, 2024
Dengue virus (DV) non-cross-reactive Omicron wave COVID-19 serums enhanced DV3 infectivity <i>in vitro</i>Supratim Sarker, Chiroshri Dutta, Abinash Mallick, et al.
Pageof 1